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Abstract
AIM: To identify risk factors associated with esophageal 
cancer in Zambia and association between dietary intake 
and urinary 8-iso prostaglandin F2α (8-isoPGF2α).
METHODS: We conducted a prospective, case control 
study at the University Teaching Hospital. Subjects 
included both individuals admitted to the hospital and 
those presenting for an outpatient upper endoscopy. 
Esophageal cancer cases were compared to age and 
sex-matched controls. Cases were defined as patients 
with biopsy proven esophageal cancer; controls were 
defined as subjects without endoscopic evidence of 
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Case Control Study
Esophageal squamous cell cancer in a highly endemic 
region
the two most common esophageal cancers worldwide. 
EA is most common in the western world (North 
America, Europe), whilst ESCC is most common in 
Africa, South America and China[4]. Data suggests an 
increasing trend (500% increase) of EA over the past 
30 decades in Western world[5] and decreasing rates of 
ESCC[4]. In Sub-Saharan Africa, there is an increasing 
trend of ESCC, attributed to several factors including 
improved diagnostic capabilities and changing 
behaviour (smoking, obesity)[6]. In a systematic review 
evaluating the epidemiology of esophageal cancer in 
sub-Saharan Africa, Kachala reports an increase in 
esophageal cancer, predominantly ESCC, with varying 
incidence rates within the continent ranging from, 0.6 
to 76.6/100000 and 0.6 to 36.5/100000, in males and 
females respectively[6]. In a retrospective study at the 
University Teaching hospital (UTH), Lusaka, Zambia, 
Kelly et al[7] found 96% of esophageal cancers were 
ESCC. The overall incidence of esophageal cancer in 
Zambia is estimated to be 9.1/100000[1], more than 
in United States (3-4/100000) or United Kingdom 
(6.5/100000). 
Information regarding esophageal cancer within 
most countries in Africa is poor, primarily due to under-
reporting because of lack of diagnostic resources and 
limited manpower[7]. Zambians with esophageal cancer 
often present with disease at a late stage, probably 
due to financial constraints and access to health care 
facilities[2]. According to GloboCan 2012, esophageal 
cancer is the 5th leading cause of cancer mortality in 
Zambia[1]. However, the age of onset of esophageal 
cancer is younger in the Zambian population compared 
to the United States and United Kingdom. Kelly et al[7] 
found that 28% of patients with esophageal cancer 
were younger than 45 years of age, compared to the 
United States or United Kingdom in which new cases 
occurring in individuals younger than 50 years of age 
were 7.6% and less than 10% respectively[8,9]. The 
phenomenon of esophageal cancer in young people 
has also been observed in Kenya. Of 2643 newly 
diagnosed cancers, 914 (34.6%) were esophageal 
cancer; of which 58 (6.3%) patients were under 30 
years, 9 (1%) under 20 years, with the youngest 
patient diagnosed at age 14 years[2]. We propose 
that elucidation of the basis for this age difference 
may reveal important clues to the etiology and 
pathogenesis of esophageal cancer.
A review of the literature reveals that risk factors for 
esophageal cancer include environmental, lifestyle (diet, 
smoking and alcohol consumption), infectious, and 
genetic factors[3,10-14]. Alcohol consumption has been 
primarily associated with ESCC whilst smoking is a risk 
factor for both squamous cell and adenocarcinoma[3]. 
The specific dietary factors include vitamin/trace metal 
deficiencies, and increased nitrites and nitrosamines[15]. 
Dietary antioxidants, such as those found in fresh 
fruits and raw vegetables, particularly green leafy 
vegetables, are thought to play a protective role in 
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esophageal cancer. Clinical and dietary data were 
collected using a standard questionnaire, developed 
a priori . Blood was collected for human immunodefi-
ciency virus (HIV) serology. Urine was collected, and 
8-isoPGF2α was measured primarily by enzyme-linked 
immunosorbent assay and expressed as a ratio to 
creatinine.
RESULTS: Forty five controls (mean age 54.2 ± 15.3, 
31 male) and 27 cases (mean age 54.6 ± 16.4, 17 
males) were studied. Body mass index was lower in 
cases (median 16.8) than controls (median 23.2), P  = 
0.01. Histopathologically, 25/27 (93%) were squamous 
cell carcinoma and 2/27 (7%) adenocarcinoma. 
More cases smoked cigarettes (OR = 11.24, 95%CI: 
1.37-92.4, P  = 0.02) but alcohol consumption and HIV 
seropositivity did not differ significantly (P  = 0.14 for 
both). Fruit, vegetables and fish consumption did not 
differ significantly between groups (P  = 0.11, 0.12, 
and 0.10, respectively). Mean isoprostane level was 
significantly higher in cases (0.03 ng/mg creatinine) 
than controls (0.01 ng/mg creatinine) (OR = 2.35, 
95%CI: 1.19-4.65, P  = 0.014).
CONCLUSION: Smoking and isoprostane levels were 
significantly associated with esophageal cancer in 
Zambians, but diet, HIV status, and alcohol consumption 
were not.
Key words: Gastrointestinal cancer; Non-communicable 
diseases; Zambia
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The most common type of esophageal cancer 
in developing countries, including Sub-Saharan Africa, 
is squamous cell carcinoma, in contrast to the United 
States and United Kingdom, in which adenocarcinoma 
predominates. Yet, there are few studies evaluating 
risk factors, antioxidant status and the role of oxidative 
stress of esophageal cancer in Africa. This study 
explores the association of a non-invasive marker for 
oxidative stress in esophageal cancer. 
Asombang AW, Kayamba V, Lisulo MM, Trinkaus K, Mudenda 
V, Sinkala E, Mwanamakondo S, Banda T, Soko R, Kelly P. 
Esophageal squamous cell cancer in a highly endemic region. 




Esophageal cancer is the eight most common cancer 
worldwide and the sixth most common cause of 
cancer death[1-3]. Esophageal adenocarcinoma (EA) 
and esophageal squamous cell carcinoma (ESCC) are 
the development of cancer[16-20]. Oxidative stress is 
a result of increase production of reactive oxygen 
species which may play a role in carcinogenesis by 
causing damage to DNA, cell structure and increase 
proliferation rate[17-21]. Antioxidants such as those 
found in diet are thought to play a role in preventing 
and repairing damage induced by the reactive oxygen 
species[5]. This study aims to test the hypothesis that 
poor antioxidant status predisposes to esophageal 
cancer in Zambia using isoprostanes measured in urine 
as a surrogate marker of oxidative stress. Isoprostanes 
are prostaglandin like substances formed by free 
radical peroxidation of arachidonic acid[21]. The increase 
isoprostane level is a marker of free radical induced 
damage that leads to DNA damage and has a role in 
carcinogenesis. In vivo formation of isoprostanes in 
humans was not discovered until the 1990s[21,22], and 
this measurement of isoprostanes is considered one 
of the most reliable methods to assess in vivo status 
of oxidative stress[21], with urinary status being least 
invasive. Oxidative stress plays a role in carcinogenesis 
by increasing DNA damage, cell proliferation and 
apoptosis.
MATERIALS AND METHODS
Institutional Review Board approval was obtained from 
the University of Zambia School of Medicine research 
ethics committee and Washington University School of 
Medicine in St Louis, United States. Informed consent 
was obtained from all patients prior to enrolling pa-
tients in the study. 
This was a prospective, case control study at the 
largest tertiary hospital, University Teaching Hospital 
(UTH) in Lusaka, Zambia, Southern Africa between 
November 2010 and January 2012. UTH is a national 
referral hospital based in Lusaka, the capital city of 
Zambia, and sees cases from all over the country, a 
catchment area of approximately 1.3 million[23].
Study design
We employed a case control study design. Cases 
and controls were matched by sex, and age (within 
age groups ≤ 30, 31-45, 46-60, or > 60 years). Our 
inclusion criteria for cases were: (1) age ≥ 18 years; 
and (2) histopathologically proven esophageal cancer; 
for controls: (1) age ≥ 18 years; and (2) upper 
gastrointestinal (GI) symptoms but no pathology 
seen at endoscopy. The exclusion criteria: (1) active 
chemotherapy or radiation therapy; and (2) inability to 
consent.
Data collection
For patients who met inclusion criteria, a questionnaire 
was used to collect demographic data (age, gender, 
occupation, socioeconomic status and education level); 
a medical history including family history, alcohol 
consumption history and smoking history); A food 
frequency questionnaire (FFQ), developed a priori by 
the research team was used to obtain dietary history. 
The FFQ was specific to the Zambian diet and 51 
food items were classified into 7 categories: Fruits, 
vegetables, fish, meat, insects, cereals and starches. 
This food questionnaire assessed habitual food 
consumption of each food item by asking frequency 
in form of never, once per month, once per week, 2-3 
times per week, 4-6 times per week, daily, 2-3 times 
per day, 4-6 times per day and 7 times per day. The 
analysis was performed of the 7 categories. A physical 
examination was performed on all subjects at initial 
enrollment. An upper endoscopy was performed 
using the Pentax 2990 series endoscopes. Cold biopsy 
forceps were used to obtain routine biopsies from 
all malignant appearing lesions for histopathology. 
Urine samples were collected to measure levels of 
isoprostanes using immunoassays. Blood samples 
were collected for human immunodeficiency virus 
(HIV). 
Lab technique for immunoassay
Urine samples were collected to measure isoprostanes 
(8-iso prostaglandin F2α) using enzyme-linked 
immunosorbent assay (ELISA). In our prior study 
the use of ELISA was validated by comparing results 
against the gas chromatography/mass spectrometry[24]. 
Butylated hydroxytoluene (BHT) preservative stock 
solution was prepared with 50 mg/mL methanol and 
stored in a refrigerator at +4 degrees Celsius. Fasting 
spot urine samples were collected from all subjects; 
aliquots of 0.9 mL was added to 0.1 mL BHT in a 
cryopreservation tube then stored at -80 ℃. Urinary 
isoprostane and creatinine concentrations were 
measured using Isoprostane and Creatinine Microplate 
Assays (Oxford Biomedical, Oxford, MI) according to 
the manufacturer’s instructions.
Statistical analysis
Data was analyzed using SAS. The cases and control 
were matched by age, so they are not independent 
cohorts of patients. Conditional logistic regression 
was used to take into account the matching while 
estimating the overall risk of esophageal cancer 
associated with smoking, alcohol consumption, HIV 
positive status, isoprostane and creatinine levels 
and standardized food consumption frequencies. 
The following variables were categorized and thus 
we were able to analyze them as dichotomous or 
polytomous independent variables using conditional 
logistic regression: age (< 30, 31-45, 46-60, > 
60), education (none, primary, secondary, tertiary) 
and income (high vs low). The following were not 
categorized, but analyzed as continuous variables: 
BMI and MUAC. Mean isoprostane level was analyzed 
on a log scale to improve the fit of the logistic model. 
The odds of esophageal cancer were calculated per 
one unit increase in log isoprostane level. The results 
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and controls (23.2) differed, and was statistically 
significant, P = 0.014. Social history revealed more 
cases than controls smoked, OR = 11.24, 95%CI: 
1.37-92.4, P = 0.02. Neither alcohol consumption nor 
HIV seropositivity were statistically significant, P = 
0.14 for both. Histopathologically, 25/27 (93%) cases 
were squamous cell carcinoma and 2/27 (7%) were 
adenocarcinoma. The location of the malignant lesions 
in the esophagus was as follows: 4/27 in the upper 
third, 6/27 in the middle and 4 in the lower third. 
Lesion location documentation was missing for 13 of 
the 27 cases.
Smoking and alcohol status
Ever having smoked (that is, current or former smoker) 
was more common among cases than among controls 
(OR = 11.2, P = 0.024). Being a current smoker was 
not demonstrably more common in either group (P = 
0.21) (Table 2). Ever having smoked and ever having 
consumed alcohol (that is, having been both a smoker 
and a drinker, vs having done only one or neither of 
these things) was also more common among cases 
than controls (OR = 9.3, P = 0.040). This effect may 
be mostly due to smoking. 
Food frequency questionnaire estimation of dietary 
intake
Standardized food frequencies did not differ in cases 
and controls, although total fruits, total vegetables 
and total fish may have higher values in controls (P 
= 0.11, 0.12 and 0.10, respectively). After correction 
for multiple testing none of the individual foods are 
clearly more commonly consumed with either cases or 
controls (individual food results not shown here).
Urinary isoprostane excretion
The mean isoprostane excretion into urine was 
significantly higher in cases (0.03 ng/mg creatinine) 
than controls (0.01 ng/mg creatinine), OR = 2.35, 
95%CI: 1.19-4.65, P = 0.014. We found the higher 
isoprostane levels are associated with esophageal 
are expressed as odds ratio with a 95%CI. P values 
test the null hypothesis that each of the following 
risk factors is equally likely to be present in those 
with esophageal cancer and in the controls with no 
esophageal cancer. A P value of less than 0.05 was 
considered to be statistically significant. Sample size 
calculations were based on a matched case-control 
study design. Given that there are few baseline data 
are available, the assumptions made were plausible 
but not necessarily accurate. We assumed that 20% 
of the controls have high isoprostane levels (indicating 
high levels of oxidative stress), and 50% of cases have 
high isoprostane levels, with 95% confidence and 90% 
power, we thus required 58 cases and 58 controls. 
RESULTS
Patient characteristics 
During the study period, we enrolled patients from 
across the country, 27 with esophageal carcinoma 
and 45 controls. We analyzed 27 case-control sets, 
11 with one control and 16 with 2 controls per case. 
Of the 45 controls, 31 were males with a mean age 
of 54.2 years (SD ± 15.3) and of the 27 cases, 17 
were males with a mean age of 54.67 years (SD ± 
16.4) (Table 1). The median BMI for cases (16.8 kg/m2) 
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Table 2  Logistic regression models of association of risk 
factors with esophageal cancer
Risk factor Odds ratio 95%CI P  value
Isoprostane excretion (log)   2.35   1.19-4.65 0.014
Current/former smoker vs never 11.24     1.37-92.40 0.024
Current/former alcohol use vs 
never
  2.49 0.744-8.34 0.140
HIV seropositive 3.450   0.656-18.14 0.140
Total fruits 0.761 0.542-1.07 0.110
Total vegetables 0.917 0.822-1.02 0.120
Total fish 0.364 0.108-1.23 0.100
Total animal products 0.555 0.162-1.90 0.350
Total insects 4.220   0.463-38.42 0.200
Associations between risk factors and cancer are presented as OR with 
95%CI, and a P value of < 0.05 was required for statistical significance. 
HIV: Human immunodeficiency virus.
Table 1  Baseline characteristics  n  (%)
Variable Case (n  = 27) Control (n  = 45) P  value
Age group
   < 30 yr   2 (7.41)   2 (4.4) (reference)
   31–45 yr   7 (26.0) 14 (31.1) 0.99
   46–60 yr   6 (22.2) 11 (24.4) 0.99
   > 60 yr 12 (44.4) 18 (40.0) 0.99
Gender
   Male 17 (63) 31 (69) 0.99
   Female 10 (37) 14 (31) (reference)
Education
   None 2 (8.3) 4 (8.9) (reference)
   Primary 15 (62.5) 18 (40.0) 0.76
   Secondary 6 (25) 11 (24.4) 0.66
   Tertiary  1 (4.1) 12 (26.7) 0.99
Income
   Low 21 (77.8) 15 (33.3) (reference)
   High 2 (7.4) 14 (31.1) 0.025
   Irregular/unsure   4 (14.8) 16 (35.6) 0.019
Smoking status
   Never 19 (70) 42 (93) (reference)
   Ever   8 (30) 3 (7) 0.024
Alcohol intake
   Never 18 (67) 37 (82) (reference)
   Ever   9 (33)   8 (18) 0.140
Median BMI (kg/m2) 16.8 24.5 0.014
HIV 
   Positive   6 (22.2) 3 (6.7) 0.140
   Negative 20 (74.1) 38 (84.4) (reference)
MUAC (cm) 21.5 (19-25)   28 (26-31)   0.0024
Low income: less than $200 per month; Ever smoked or drank alcohol 
includes both current and former. A P value of < 0.05 was statistical 
significant. BMI: Body mass index; MUAC: Mid upper arm circumference; 
HIV: Human immunodeficiency virus.
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cancer compared to the controls, P = 0.014. The risk 
increases by about 2.4 times with each unit increase 
on a log scale. There is no evidence that creatinine 
levels are associated with esophageal cancer (P = 
0.11).
DISCUSSION
Esophageal cancer poses a significant global health 
burden, with majority of cases and deaths occurring 
in highly endemic areas, Asia and Southern Africa[1]. 
Late presentation especially in cases of ESCC has been 
identified as one of the risks for poor outcome and 
death[25]. Given the poor morbidity and mortality, it is 
important to understand the etiopathogenesis of cancer 
and develop tools for early detection. An increase in 
isoprostane levels has been found in association with 
other disorders such as cardiovascular (heart failure), 
pulmonary (asthma), neurologic (multiple sclerosis[26], 
hepatic (cirrhosis) and cancers (prostate, breast)[21,22]. 
Oxidative stress has been implicated in various 
disorders including cancer of the prostate[27,28], lung[29], 
and breast[30]. An imbalance between pro-oxidant and 
antioxidants results in oxidative stress, and this may 
promote carcinogenesis. The advantage of measuring 
urinary isoprostanes as a marker of oxidative stress is 
that it is postulated to be chemically stable, detectable 
in all tissues hence allowing for normal range definition 
and evidence from animal models showing an increase 
in the setting of oxidative injury[21]. The prognostic 
aspect of F2 isoprostanes shows a direct relationship 
between isoprostane and disease state, specifically a 
higher level with increasing severity in conditions such 
as asthma explained by worsening inflammation[21]. 
However, there is not sufficient evidence to apply this 
direct relationship in the development and progression 
of esophageal squamous cell cancer.
In this study, we report risk factors associated with 
esophageal cancer in Zambians. This study contributes 
to what is currently known about the role of diet, 
oxidative stress and antioxidants in carcinogenesis. We 
found that smoking and elevated urinary isoprostane 
levels were associated with esophageal cancer in the 
Zambian patients, but diet composition, HIV status, 
and alcohol consumption were not. To our knowledge 
this is the first prospective study evaluating dietary 
factors and urinary isoprostane as a marker of 
oxidative stress as risk factors for esophageal cancer 
in Zambia. This is also one of a handful of publications 
related to esophageal cancer risk factors in Zambia. 
Our hypothesis was that poor antioxidant status as 
evidenced by poor dietary antioxidants predisposes 
to esophageal cancer in Zambia and the use of 
isoprostanes measured in urine was as surrogate 
non-invasive marker of oxidative stress. However, 
our analysis revealed that the consumption of total 
fruit, vegetables and fish consumption did not differ 
significantly between esophageal cancer cases and 
controls. The mean isoprostane level was significantly 
higher in esophageal cases than controls, which 
cannot be explained by dietary factors alone. A factor 
to consider is the smoking status of subjects and role 
in carcinogenesis. There is some evidence suggesting 
that cigarette smoking results in increase in oxidative 
stress given the oxidant content[31-33], thus would 
play a role in carcinogenesis. However, there is also 
data supporting the fact that many in the esophageal 
squamous cell carcinoma high risk areas do not smoke 
or consume significant amount of alcohol to explain 
the increase incidence and prevalence of ESCC. This is 
an area requiring further research. 
The role of dietary factors, such as meat in eso-
phageal carcinogenesis is inconsistent, attributing to 
the method by which the meat was prepared - boiled, 
fried or grilled[5]. There are also data supporting the 
role of carbohydrates in esophageal carcinogenesis, 
however this data is inconclusive with some studies 
showing an inverse association[5]. The Zambian diet 
is rich in carbohydrates with the main daily meal 
consisting of Nshima (a maize flour based food); 
however we do not believe this confounded our 
results given that Nshima is a staple part of the diet 
and consumed by all participants. The International 
Agency for Research on Cancer (IARC) working group 
has identified alcohol as a human carcinogen and 
implicated its role in ESCC; however in regards to red/
processed meat the conclusion is “limited suggestive 
increase”. There are several studies evaluating the 
role of diet in esophageal carcinogenesis with fewer 
differentiating the histologic subtype[34]. As mentioned, 
meat has been one of the most widely studied food 
items with inconsistent results. Most published studies 
are from Western nations such as United States, 
Europe, Asia and Australia. In a systematic review and 
dose response meta-analysis evaluating meat, fish 
and esophageal cancer risk, Salehi et al[34] analyzed 
35 articles, of which 14 focused on ESCC and 13 did 
not differentiate ESCC from EAC. There was an overall 
positive association between red meat and those with 
ESCC[34]. The mechanism of red meat in carcinogenesis 
is believed to be related to pro-oxidant property of 
heme iron. The difference of meat consumption in 
Western countries vs Asian countries has to do with 
the meat being more processed in Western nations; 
however both processed and red meat contains 
N-nitroso compounds and heme iron[34]. Red meat is 
consumed more than processed meat in the Zambian 
population, with 20%-30% of households from most 
major cities[35]. We found no significant difference in 
meat consumption between controls and cases.
There are several limitations to our study. First 
patients with esophageal cancer may change their diet 
due to dysphagia or other clinical features related to 
cancer. However, the use of FFQ has the advantage 
of capturing diet overtime including prior to being 
symptomatic. Secondly, we cannot ascertain if the 
poor antioxidant status in patients with esophageal 
cancer is a cause or consequence of the cancer. 
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Thirdly, we did not measure the antioxidant content 
of the food items, proportion or mode of preparation. 
Finally, we did not achieve our calculated sample size 
due to limitations in research funding; however our 
data contributes significantly to current knowledge 
about esophageal cancer. There are also numerous 
strengths to this study. First this was a prospective, 
case control study that included subjects both hospital 
and community based setting. Secondly, the FFQ 
was developed a priori specific to the Zambian diet, 
but can also be applied to other countries within the 
region. Third, this study contributes significantly to 
the understanding of esophageal cancer and role of 
urinary isoprostanes as a non-invasive marker of 
oxidative stress. This knowledge can be used to guide 
further studies evaluating risk factors as it relatives to 
oxidative injury and carcinogenesis.
In conclusion, identifying risk factors for esophageal 
cancer is important, so as to characterize modifiable 
risks that can be altered with behavioural changes and 
thus contribute to decreasing overall disease incidence 
or set-up screening protocols for individuals at risk. To 
our knowledge there are no global guidelines for ESCC 
screening, however several techniques have been 
studied to identify precursor lesions. Screening and 
surveillance guidelines for Barrett’s esophagus have been 
developed by the American Society for Gastrointestinal 
Endoscopy (ASGE), but no concrete guidelines exist for 
ESCC. Further studies are encouraged to understand 
the role of urinary isoprostanes in screening and 
progression of esophageal squamous cell cancer.
COMMENTS
Background
Globally, esophageal cancer poses significant morbidity and mortality with an 
increasing trend in sub-Saharan Africa. Broadly there are two main subtypes: 
adenocarcinoma and squamous cell carcinoma. The squamous cell carcinoma 
predominates in the developing countries, including sub-Saharan Africa, yet 
there are limited published studies from affected regions such as Zambia, 
Southern Africa. Interestingly, the age of presentation for esophageal cancer 
in the Zambian population is younger (less than 45 years) when compared 
to developed nations such as United States or United Kingdom. Recognizing 
risk factors (i.e., genetic, dietary, environmental) is important in understanding 
carcinogenesis and developing tools for early detection and prevention of 
esophageal cancer. Oxidative stress plays a role is carcinogenesis via tumour 
cell proliferation and DNA damage. The ability of measuring oxidative stress 
could play a role in early detection of esophageal cancer and prevention of 
progression as a monitoring tool.
Research frontiers
One of the most reliable methods to assess in vivo status of oxidative stress 
is the measurement of isoprostanes. Urinary isoprostanes have been studied 
in other cancers (prostate, breast) as a marker of oxidative stress. To the best 
of the authors’ knowledge, there are no published studies from Sub-Saharan 
Africa exploring the role of isoprostanes as a marker of oxidative stress in 
esophageal cancer. 
Innovations and breakthroughs
The aim of this study was to identify risk factors associated with esophageal 
cancer in Zambia and association between dietary intake and urinary 8-iso 
prostaglandin F2α. There are no studies from Zambia or other sub-Saharan 
countries exploring this association. Oxidative stress has been implicated 
in various disorders including cancer of the prostate, lung, and breast. An 
imbalance between pro-oxidant and antioxidants results in oxidative stress, 
and this may promote carcinogenesis. This study contributes to what is 
currently known about the role of diet, oxidative stress and antioxidants in 
carcinogenesis. 
Applications
Urinary isoprostanes could potentially serve as a biomarker for oxidative stress 
in individuals with esophageal cancer. Further studies are needed to explore 
role of isoprostanes in early detection of esophageal cancer and monitoring of 
treatment in those with diagnosed esophageal cancer.
Terminology
Oxidative stress plays a role in carcinogenesis by increasing DNA damage, 
cell proliferation and apoptosis. Oxidative stress is an imbalance between free 
radicals (unstable, reactive) and antioxidants, with resulting damage induced by 
free radicals. Urinary isoprostanes are prostaglandin like substances that can 
be measured in urine as markers of oxidative stress. Oxidative stress has been 
recognized in the development of cancer; hence urinary isoprostanes can be 
used as a non-invasive marker of oxidative stress. 
Peer-review
This prospective, case control study provides more data about the association 
of isoprostanes with carcinogenesis and to our knowledge this is one of the first 
few studies exploring the role in esophageal cancer in Sub-Saharan Africa. This 
study contributes to current knowledge of esophageal cancer and risk factors. 
Information from this study could be used for further studies, development of 
screening protocols and management of esophageal cancer.
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